Edelweiss Lifecare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.50 M
as on 04-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.19 M
as on 04-12-2024
- Revenue -9.62%
(FY 2020)
- Profit -7.82%
(FY 2020)
- Ebitda -10.92%
(FY 2020)
- Net Worth 14.11%
(FY 2020)
- Total Assets 24.24%
(FY 2020)
About Edelweiss Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.19 M.
Rajeev Kumar and Pratibha Kumari serve as directors at the Company.
- CIN/LLPIN
U24232CH2012PTC033485
- Company No.
033485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Edelweiss Lifecare Private Limited offer?
Edelweiss Lifecare Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Nutraceuticals & Dietary Supplements, Dietary Supplements, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Common Disease Medicines, Pharmaceutical Capsules, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant.
Who are the key members and board of directors at Edelweiss Lifecare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Kumar  | Director | 16-Jan-2012 | Current |
| Pratibha Kumari | Additional Director | 22-Feb-2024 | Current |
Financial Performance of Edelweiss Lifecare.
Edelweiss Lifecare Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 9.62% decrease. The company also saw a slight decrease in profitability, with a 7.82% decrease in profit. The company's net worth Soared by an impressive increase of 14.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edelweiss Lifecare?
In 2020, Edelweiss Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 10 Aug 2020 | ₹0.19 M | Open |
Canara Bank Creation Date: 18 May 2016 | ₹4.00 M | Open |
How Many Employees Work at Edelweiss Lifecare?
Unlock and access historical data on people associated with Edelweiss Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edelweiss Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edelweiss Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
